SureTrader Stock Hero Advertisement SureTrader SPDR Advertisement
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
Member Level 
Followed By 1,170
Posts 135,634
Boards Moderated 8
Alias Born 01/25/09
160x600 placeholder
PharmaCyte Biotech's Melligen Cells Prove Safe in First Preclinical Test "GlobeNewswire Inc." - 5/6/2015 9:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/29/2015 9:01:24 AM
PharmaCyte Biotech Finalizes International Diabetes Consortium to Cure Diabetes "GlobeNewswire Inc." - 4/20/2015 9:30:00 AM
PharmaCyte Biotech Appoints Former Pfizer and Alchemia Executive to Board of Directors "GlobeNewswire Inc." - 4/14/2015 9:30:00 AM
New Research Shows PharmaCyte Biotech's Melligen Cell Line Can Reverse Diabetes "GlobeNewswire Inc." - 4/10/2015 9:30:00 AM
PharmaCyte Biotech on Track to Commence Clinical Trials "GlobeNewswire Inc." - 3/27/2015 9:00:00 AM
PharmaCyte Biotech Provides Update on Corporate Developments and Progress With Cancer and Diabetes Programs "GlobeNewswire Inc." - 3/16/2015 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 3/13/2015 5:27:17 PM
PharmaCyte Biotech Announces Launch of New Corporate Website "GlobeNewswire Inc." - 3/9/2015 10:48:29 AM
Building A 'Risk-Adverse' Pot Stock Portfolio "Seeking Alpha" - 3/9/2015 1:06:20 AM
Pot Stock Crash Redux: $23.3B Loss? "Seeking Alpha" - 3/8/2015 1:42:05 AM
48 Marijuana Stocks - A Post-Mortem: Part I "Seeking Alpha" - 3/3/2015 2:27:42 AM
PharmaCyte Biotech's Scientific Advisory Board Chairman Publishes Review Article on the Pathology of Pancreatic Cancer "GlobeNewswire Inc." - 2/24/2015 9:30:00 AM
PharmaCyte Biotech Initiates Expanded Follow-up Study in the United States on the Accumulation of Malignant Ascites Fluid "GlobeNewswire Inc." - 2/19/2015 9:30:00 AM
PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article on Use of Genetic Engineering to Treat Diabetes "GlobeNewswire Inc." - 2/13/2015 9:00:00 AM
PharmaCyte Biotech's International Diabetes Consortium Sets Path Forward to Develop Novel Treatment for Diabetes "GlobeNewswire Inc." - 2/10/2015 9:00:00 AM
PharmaCyte Biotech Initiates First Preclinical Study of Its Encapsulated Cell Product for Novel Treatment of Diabetes "GlobeNewswire Inc." - 2/2/2015 9:00:00 AM
PharmaCyte Biotech's Partner Austrianova Opens New Facilities in Singapore "GlobeNewswire Inc." - 1/29/2015 9:00:00 AM
PharmaCyte Biotech's Expanded Follow-up Study on Malignant Ascites Fluid Accumulation in Final Stages of Preparation "GlobeNewswire Inc." - 1/26/2015 9:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 1/20/2015 4:49:52 PM
PharmaCyte Biotech's Pancreatic Cancer Treatment Named as Near-Term Approach to Rising Pancreatic Cancer Rates "GlobeNewswire Inc." - 1/15/2015 9:00:00 AM
PharmaCyte Biotech Announces Update on Corporate Changes "GlobeNewswire Inc." - 1/8/2015 9:00:00 AM
NYC Trader Member Level  Friday, 05/10/13 07:49:08 AM
Re: None
Post # of 36027 
Ticker: $NVLX
OTC Market Tier: OTCQB
CIK code: 0001157075
Company name: Nuvilex, Inc.
Company website:
Incorporated In: NV, USA

Visit my board"NY Penny Stock Exchange" for today's pick at
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist